Circulating hematopoietic stem cells in patients with idiopathic choroidal neovascularization

Manabu Sasahara1, Atsushi Otani, Yuko Yodoi

  • 1Department of Ophthalmology and Visual Sciences, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto, Japan.

Insights

Impaired circulating hematopoietic stem cells (HSCs) were found in patients with idiopathic choroidal neovascularization (iCNV). These functional deficits in HSCs correlate with iCNV size, suggesting their role in disease development.

Area of Science:

  • Ophthalmology
  • Stem Cell Biology
  • Pathogenesis Research

Background:

  • Age-related macular degeneration (AMD) studies previously linked circulating hematopoietic stem cells (HSCs) to choroidal neovascularization (CNV).
  • The specific role of HSCs in idiopathic CNV (iCNV) pathogenesis remained unclear.

Purpose of the Study:

  • To investigate the function of circulating HSCs in patients with iCNV.
  • To determine if HSC activity correlates with iCNV severity.

Main Methods:

  • A case-control study involving 13 iCNV patients and 10 healthy controls.
  • Analysis of colony-forming capacity, migration, and invasion of cultured patient-derived HSCs.
  • Comparison of HSC function between iCNV patients and controls, and correlation with CNV size.

Main Results:

  • HSCs from iCNV patients showed significantly lower colony-forming capacity (CFU-Hill) compared to controls (12.8 vs. 67.6).
  • Invasion activity of HSCs was also significantly reduced in iCNV patients.
  • Impaired CFU-Hill correlated with larger CNV lesion size (>1500 microm).

Conclusions:

  • Circulating HSCs exhibit impaired function in patients with iCNV, mirroring findings in AMD-related CNV.
  • Reduced HSC activity is associated with iCNV severity, supporting their pathogenic role.
  • These findings highlight the involvement of HSCs in the development of iCNV.
Abstract

Related Concept Videos

Multipotency of Hematopoietic Stem Cells01:19

Multipotency of Hematopoietic Stem Cells

The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...